aciddegrad
cation
nanoparticl
encapsul
model
antigen
ie
ovalbumin
prepar
invers
microemuls
polymer
acidcleav
acet
crosslink
incub
degrad
nanoparticl
dendrit
cell
deriv
bone
marrow
bmdc
result
enhanc
present
ovalbuminderiv
peptid
quantifi
cell
cell
hybridoma
cation
natur
particl
contribut
increas
surfac
endocytosi
phagocytosi
observ
bmdc
first
barrier
overcom
success
antigen
deliveri
acid
sensit
particl
serv
direct
ovalbumin
antigen
process
appropri
trim
peptid
fragment
present
via
major
histocompat
complex
mhc
class
pathway
follow
hydrolysi
within
acid
lysosom
also
shown
adjuv
molecul
unmethyl
cpg
oligonucleotid
cpg
odn
oligonucleotid
odn
could
codeliv
protein
antigen
maxim
cellular
immun
respons
sinc
introduc
roughli
two
centuri
ago
smallpox
vaccin
significantli
contribut
human
health
one
effect
tool
prevent
treat
fatal
diseas
tradit
either
whole
inactiv
live
attenu
microorgan
inject
howev
method
sometim
lead
side
effect
rang
mild
unaccept
recent
purifi
recombin
macromolecul
pathogen
surfac
protein
polysaccharid
use
increasingli
clinic
trial
minim
possibl
side
effect
addit
knowledg
work
immun
system
molecular
level
acquir
effort
direct
toward
develop
highli
effici
safe
vaccin
diseas
aid
cancer
previous
elud
treatment
via
vaccin
cancer
immunotherapi
identifi
one
plausibl
altern
convent
chemotherapi
radiotherapi
surgeri
possess
mani
uniqu
advantag
includ
highli
specif
deliveri
target
cell
memori
preimmun
diseas
simpl
administr
eg
inject
inhal
aerosol
vaccin
skin
patch
detail
inform
mechan
diseas
becom
avail
deliveri
therapeut
molecul
becom
one
import
target
develop
success
vaccin
strategi
activ
immun
system
vaccin
requir
deliveri
suffici
amount
antigen
antigen
present
cell
apc
macrophag
dendrit
cell
ii
control
present
antigen
molecul
target
immun
cell
andor
cell
iii
prolifer
effector
cell
cytotox
lymphocyt
ctl
plasma
b
cell
iv
mainten
activ
immun
system
desir
period
time
howev
univers
vaccin
system
display
requir
develop
thu
far
deliv
antigen
phagocyt
apc
variou
deliveri
system
liposom
microparticl
nanotub
studi
use
deliveri
vehicl
antigen
mix
adjuv
molecul
bacteri
lipopolysaccharid
lp
demonstr
prolong
immun
respons
increas
local
inflamm
intern
antigen
process
either
endogen
exogen
pathway
endogen
antigenderiv
peptid
present
major
histocompat
complex
mhc
class
molecul
activ
cytotox
lymphocyt
ctl
mediat
immun
respons
cellular
immun
bind
cell
receptor
contrast
antibodymedi
respons
also
refer
humor
immun
activ
exogen
antigenderiv
peptidemhc
ii
complex
apc
therefor
presum
desir
immun
respons
achiev
control
antigen
present
pathway
cellular
immun
respons
report
effect
remov
infect
cell
cancer
humor
immun
previou
studi
shown
increas
mhc
antigen
present
achiev
prime
apc
antigenencapsul
aciddegrad
nanoparticl
degrad
acid
ph
follow
phagocytosi
releas
antigen
cytoplasm
studi
model
antigen
ovalbumin
encapsul
cation
aciddegrad
nanoparticl
incub
potent
profession
apc
dendrit
cell
dc
result
increas
endocytosi
nanoparticl
present
ovalbumin
mhc
molecul
dc
also
shown
maxim
immun
respons
might
achiev
simpli
coat
adjuv
oligonucleotid
cation
surfac
nanoparticl
degrad
nanoparticl
prepar
invers
microemuls
polymer
method
follow
nonion
surfact
span
tween
aldrich
st
loui
mo
dissolv
hexan
concentr
w
w
air
remov
sparg
dri
nitrogen
overnight
aqueou
solut
monom
prepar
dissolv
acrylamid
biorad
hercul
ca
chlorid
aetmac
aldrich
mg
ammonium
persulf
ap
biorad
acidlabil
benzyl
acet
crosslink
al
phosphat
buffer
salin
pb
ph
contain
mgml
ovalbumin
sigma
st
loui
mo
aqueou
solut
monom
combin
ml
organ
surfact
solut
vigor
shake
mixtur
min
polymer
initi
addit
al
n
n
tetramethylethylenediamin
teme
sigma
mixtur
stir
min
ad
excess
aceton
time
volum
organ
surfact
solut
settl
clump
nanoparticl
follow
addit
min
gentl
stir
stand
h
precipit
pellet
wash
aceton
dri
vacuum
overnight
chang
ratio
aetmac
acrylamid
variou
cation
nanoparticl
prepar
fix
crosslink
ratio
comparison
nondegrad
polyacrylamid
nanoparticl
made
use
acrylamid
n
methylenebisacrylamid
biorad
size
surfac
charg
nanoparticl
measur
use
dynam
light
scatter
dl
particl
sizer
zeta
potenti
analyz
zetas
nano
zs
malvern
instrument
malvern
uk
nanoparticl
suspend
mgml
ph
pb
gibco
brl
bethesda
md
size
measur
ph
buffer
made
mm
hepe
mm
nacl
zetapotenti
analysi
transmiss
electron
microscopi
tem
nanoparticl
suspens
pb
spot
onto
formvarcarbon
grid
ted
pella
red
ca
min
grid
wash
distil
water
twice
dri
room
temperatur
h
minim
hydrolysi
particl
sampl
examin
immedi
dri
philip
tecnai
transmiss
electron
microscop
kv
diamet
randomli
chosen
nanoparticl
estim
tem
imag
use
nih
imag
version
nih
bethesda
md
amount
protein
encapsul
determin
use
ovalbumin
conjug
phinsensit
cascad
blue
dye
molecular
probe
eugen
label
protein
prepar
accord
protocol
provid
manufactur
particl
hydrolyz
incub
mm
acet
acid
buffer
ph
h
room
temperatur
ovalbumin
concentr
quantifi
measur
cascad
blue
fluoresc
obtain
excit
solut
nm
detect
emit
nm
wavelength
use
fluoresc
plate
reader
dendrit
cell
obtain
use
slightli
modifi
literatur
procedur
briefli
femur
tibia
month
old
femal
mice
jackson
laboratori
bar
harbor
extract
euthanasia
bone
marrow
flush
use
gaug
needl
ml
medium
supplement
vv
fetal
bovin
serum
fb
hyclon
logan
ut
uml
penicillin
agml
streptomycin
mm
lglutamin
mm
sodium
pyruv
gibco
red
blood
cell
remov
treat
rbc
lysi
buffer
gentra
system
minneapoli
mn
remain
cell
cultur
medium
given
earlier
supplement
vv
granulocytemacrophag
coloni
stimul
factor
gmcsf
contain
supernat
gener
donat
dr
edward
jame
uc
berkeley
day
cultiv
plate
suspend
cell
inocul
onto
plate
densiti
cellswel
amount
present
ovalbuminderiv
peptid
ova
siinfekl
mhc
class
molecul
k
b
measur
vitro
cellular
assay
immunoassay
bmdc
incub
vari
amount
ovalbuminload
nanoparticl
h
wash
extens
ph
pb
cell
hybridoma
cell
well
coincub
overnight
bmdc
hybridoma
express
lacz
upon
bind
cell
receptor
tcr
siinfeklk
b
medium
replac
al
cprg
buffer
contain
mg
chlorophenol
red
hdgalactopyranosid
cprg
roch
indianapoli
mg
emd
scienc
la
jolla
ca
ml
mgcl
aldrich
l
pb
amount
lacz
enzym
quantifi
hydrolysi
cprg
produc
chlorophenol
red
absorb
nm
quantiti
siinfekl
k
b
calcul
comparison
uv
absorpt
valu
obtain
free
siinfekl
peptid
incub
dc
refer
minim
ph
drop
might
result
lactic
acid
accumul
particl
ad
fresh
medium
incub
dc
h
particl
uptak
antigen
present
experi
respect
chang
color
medium
observ
experi
suggest
signific
ph
chang
taken
place
sinc
slight
ph
drop
would
turn
medium
yellow
sinc
phenol
red
work
narrow
rang
ph
visual
siinfeklk
b
complex
densiti
bmdc
surfac
cell
cultur
cm
round
collagen
icoat
coverslip
bd
bioscienc
bedford
one
well
plate
incub
mg
nanoparticl
ml
medium
h
wash
pb
twice
cell
fix
paraformaldehyd
buffer
follow
wash
pb
fb
cell
incub
h
monoclon
antibodi
mab
supernat
produc
b
cell
hybridoma
gift
dr
ronald
germain
niaid
nih
bethesda
md
wash
pb
fb
ag
rphycoerythrin
pe
conjug
goat
antimous
polyclon
antibodi
pharmingen
san
diego
ca
ad
ml
pb
fb
cell
incub
addit
hour
wash
twice
coverslip
place
glass
slide
examin
use
laserscan
confoc
microscop
carl
zeiss
thornwood
ny
ovalbumin
conjug
fluoresceinlik
phinsensit
alexa
fluor
succinimidyl
ester
molecular
probe
bmdc
incub
mg
label
ovalbuminload
nanoparticl
per
well
plate
h
wash
trypsin
analyz
use
beckmancoult
epic
xlmcl
flow
cytomet
kinet
endocytosi
bmdc
determin
examin
mean
channel
valu
averag
fluoresc
intens
threshold
level
ie
fluoresc
untreat
cell
refer
test
cytotox
bmdc
per
well
plate
incub
variou
amount
aciddegrad
cation
nanoparticl
h
extens
wash
three
time
medium
cell
cultur
addit
h
medium
aspir
al
stock
solut
contain
mg
ml
bromid
mtt
sigma
pb
ad
along
al
medium
follow
incub
h
reduc
mttformazan
product
gener
live
cell
dissolv
al
dimethylsulfoxid
al
glycin
buffer
glycin
nacl
ph
ad
rel
viabil
cell
incub
nanoparticl
untreat
cell
determin
measur
mttformazan
absorb
nm
immunostimulatori
unmethyl
cpg
oligonucleotid
cpg
odn
tccatgacgttcctgacgtt
oligonucleotid
odn
catttccgataaggcttgg
synthes
use
expedit
dna
synthes
appli
biosystem
foster
citi
ca
solut
ag
cpg
odn
ml
pb
mix
ml
cation
ovalbuminencapsul
nanoparticl
mgml
incub
ice
min
period
mix
nanoparticl
wash
resuspend
ml
medium
centrifug
rpm
twice
solut
al
resuspend
nanoparticl
medium
ad
per
well
plate
bmdc
inocul
day
prior
odn
adsorb
manner
cpg
odn
h
cultiv
amount
produc
quantifi
use
enzymelink
immunosorb
assay
elisa
kit
pierc
rockford
il
data
obtain
triplic
unless
otherwis
mention
present
mean
f
standard
deviat
statist
analyz
student
ttest
signific
level
p
b
aciddegrad
cation
nanoparticl
synthes
invers
microemuls
polymer
acrylamid
quaternari
amin
monom
aetmac
acidlabil
acet
crosslink
use
modif
method
report
previous
fig
microemuls
achiev
vigor
shake
instead
sonic
latter
may
potenti
damag
encapsul
molecul
sinc
found
particl
pellet
centrifug
alway
readili
resuspend
aqueou
solut
nanoparticl
harvest
precipit
use
graviti
treat
aceton
surfact
present
surfac
particl
wash
away
cation
surfac
expos
nonpolar
hexan
solvent
follow
settl
visibl
clump
aggreg
particl
second
aceton
wash
perform
remov
protein
surfac
particl
degre
cation
surfac
charg
easili
manipul
vari
ratio
acrylamid
aetmac
monom
tabl
although
increas
antigen
present
achiev
use
aciddegrad
particl
facilit
intern
cation
molecul
also
report
studi
knowledg
first
explor
simultan
realiz
major
goal
size
variou
cation
neutral
nanoparticl
pb
measur
use
dynam
light
scatter
regardless
cation
monom
ratio
dl
result
show
size
particl
rang
nm
diamet
fig
bridg
size
regim
pinocytosi
phagocytosi
transmiss
electron
microscopi
tem
also
confirm
size
distribut
give
averag
diamet
f
nm
fig
therefor
particl
expect
taken
exclus
phagocyt
cell
eg
macrophag
dendrit
cell
sizedepend
passiv
target
sinc
reduc
uptak
latex
particl
larger
nm
dc
report
previous
smaller
particl
prepar
effici
taken
dc
although
particl
cation
monom
display
slightli
smaller
diamet
content
cation
monom
significantli
affect
particl
size
distribut
fig
similar
size
distribut
observ
nondegrad
nanoparticl
prepar
similar
fashion
expect
zeta
potenti
rel
posit
charg
densiti
increas
ratio
cation
monom
acrylamid
increas
fig
antigen
payload
determin
hydrolysi
aciddegrad
nanoparticl
contain
encapsul
cascad
blue
labeledovalbumin
highest
ovalbumin
payload
achiev
particl
prepar
cation
monom
result
encapsul
effici
ag
mg
respect
tabl
neutral
cation
aciddegrad
nanoparticl
exhibit
lower
encapsul
effici
compar
cation
nanoparticl
amount
encapsul
protein
nondegrad
particl
determin
use
method
use
degrad
particl
due
lack
degrad
former
spectroscop
data
obtain
nondegrad
degrad
particl
solut
incub
naoh
solut
close
suggest
amount
encapsul
protein
compar
nondegrad
degrad
particl
effect
ctl
activ
antigen
must
present
mhc
molecul
carri
antigenderiv
peptid
process
cytoplasm
determin
aciddegrad
particl
increas
releas
encapsul
protein
cytosol
henc
increas
antigen
present
mhc
aciddegrad
nondegrad
particl
variou
cation
ratio
prepar
incub
bmdc
rel
amount
ovalbuminderiv
peptid
siinfekl
k
b
mhc
present
bmdc
quantifi
cultiv
hybrima
cell
line
overal
siinfekl
peptid
present
mhc
deliveri
aciddegrad
nanoparticl
nondegrad
one
fig
therefor
aciddegrad
aid
releas
ovalbumin
cytoplasm
protein
cleav
proteasom
integr
mhc
endoplasm
reticulum
er
thought
particl
taken
apc
phagocytosi
transfer
acid
lysosom
acid
sensit
crosslink
hold
particl
togeth
help
releas
protein
particl
also
deliveri
cytoplasm
ovalbumin
encapsul
nondegrad
particl
expect
releas
slowli
would
therefor
suscept
degrad
proteas
present
lysosom
peptid
present
deliv
neutral
aciddegrad
nanoparticl
high
concentr
ie
agwel
cation
nanoparticl
effect
antigen
deliveri
present
lower
concentr
agwel
cation
nanoparticl
show
highest
effici
siinfekl
present
k
b
concentr
agwel
fig
lowest
antigen
presentationeven
lower
neutral
particleswa
observ
cation
nanoparticl
concentr
agwel
detect
antigen
present
seen
use
cation
nanoparticl
concentr
agwel
wherea
neutral
particl
show
maximum
present
concentr
fig
nondegrad
nanoparticl
antigen
present
level
higher
cation
particl
neutral
particl
concentr
ag
well
fig
maximum
antigen
present
nondegrad
particl
achiev
use
cation
particl
concentr
agwel
case
aciddegrad
particl
thu
appear
cation
aciddegrad
nanoparticl
use
concentr
agwel
consti
tute
potent
antigen
deliveri
system
bmdc
stain
bmdc
siinfeklk
b
specif
mab
clearli
show
increas
antigen
present
use
aciddegrad
nanoparticl
fig
without
particl
cell
exhibit
minim
amount
autofluoresc
fig
encapsul
ovalbumin
aciddegrad
particl
increas
signal
observ
fluoresc
antibodi
indic
higher
concentr
siinfekl
peptid
present
cell
surfac
highest
fluoresc
signal
observ
bmdc
expos
aciddegrad
cation
nanoparticl
rather
neutral
particl
fig
result
correl
antigen
present
data
given
fig
cation
particl
also
exhibit
higher
present
neutral
particl
concentr
agwel
assess
use
cation
carrier
enhanc
cellular
uptak
cation
neutral
aciddegrad
nanoparticl
encapsul
ovalbumin
label
phinsensit
fluoresc
dye
alexa
fluor
incub
bmdc
h
follow
flow
cytometri
analysi
cell
incub
cation
nanoparticl
show
higher
fluoresc
intens
indic
intern
particl
cell
incub
neutral
nanoparticl
fig
cell
incub
neutral
nanoparticl
show
higher
fluoresc
other
possibl
artifact
polydispers
particl
cell
take
larger
particl
like
contain
fluoresc
ovalbumin
show
higher
fluoresc
intens
see
arrow
fig
particl
uptak
kinet
show
increas
endocytosi
cation
nanoparticl
occur
throughout
incub
period
h
fig
fluoresc
reach
plateau
h
protein
process
typic
antigen
degrad
process
insid
cell
within
timefram
h
satur
uptak
correspond
plateau
fluoresc
might
mainli
due
balanc
endocytosi
antigen
process
note
fluoresc
measur
gave
similar
result
perform
h
gentl
mix
everi
min
data
shown
high
concentr
aciddegrad
nanoparticl
decreas
antigen
present
observ
shown
fig
result
could
due
cation
natur
particl
cation
deliveri
vehicl
polyethyleneimin
pei
polyllysin
pll
shown
inhibit
cellular
viabil
prolifer
even
though
effici
taken
cell
determin
toxic
deliveri
system
aciddegrad
cation
nanoparticl
incub
bmdc
h
rel
viabil
quantifi
use
convent
mtt
assay
result
show
cytotox
nanoparticl
increas
con
centrat
regardless
cation
ratio
fig
even
decreas
viabil
observ
neutral
nanoparticl
highest
concentr
agwel
antigen
present
dramat
decreas
fig
possibl
explan
observ
cytotox
neutral
aciddegrad
nanoparticl
includ
exist
threshold
amount
particl
process
without
retard
cellular
prolifer
ii
intrins
toxic
polyacrylamid
cell
iii
cytotox
benzaldehyd
releas
hydrolysi
cation
nanoparticl
especi
sampl
show
signific
cytotox
concentr
agwel
fig
decreas
antigen
present
fig
howev
concentr
agwel
compar
cytotox
neutral
cation
nanoparticl
endocytosi
aciddegrad
neutral
nanoparticl
b
aciddegrad
cation
nanoparticl
bmdc
h
incub
endocytosi
kinet
c
aciddegrad
cation
nanoparticl
neutral
nanoparticl
bmdc
arrow
indic
cell
higher
fluoresc
intens
possibl
due
uptak
larger
particl
observ
cation
nanoparticl
show
significantli
lower
prolifer
given
toxic
antigen
present
studi
effici
cation
deliveri
system
reason
accept
concentr
appear
cation
monom
concentr
agwel
equival
mgml
particl
display
highest
antigen
present
fig
high
prolifer
fig
effici
uptak
due
posit
surfac
charg
fig
order
visual
fate
protein
taken
lysosom
compart
eventu
releas
cytoplasm
dc
incub
fluoresc
label
nondegrad
aciddegrad
cation
nanoparticl
seen
fig
intracellular
fate
two
differ
type
nanoparticl
quit
differ
ovalbumin
fluoresc
label
alexa
fluor
encapsul
deliv
via
nondegrad
particl
observ
remain
confin
within
restrict
intracellular
area
fig
dark
arrow
contrast
fluoresc
observ
throughout
cell
incub
label
aciddegrad
particl
fig
also
notic
nondegrad
particl
tend
form
aggreg
observ
degrad
particl
fig
white
arrow
degrad
particl
made
tetraglymeconjug
crosslink
possess
enhanc
dispers
report
previous
morpholog
bmdc
incub
cation
nondegrad
degrad
particl
indic
unexpect
effect
particl
degrad
dc
matur
fig
immatur
dc
special
antigen
captur
wherea
matur
dc
present
degrad
peptid
upregul
mhc
ii
costimulatori
adhes
molecul
one
typic
featur
matur
dc
uniqu
morpholog
long
thin
dendrit
thought
advantag
maxim
antigen
present
cell
junction
interestingli
bmdc
incub
cation
degrad
nanoparticl
display
highli
dendrit
surfac
fig
similar
dendrit
cell
incub
cation
nondegrad
particl
show
immatur
stellat
shape
fig
observ
suggest
degrad
particl
enhanc
antigen
present
releas
encapsul
protein
cytoplasm
also
trigger
dc
matur
although
lysosom
disrupt
aciddegrad
particl
seem
caus
bmdc
matur
mechan
event
clear
time
obvious
dc
matur
would
constitut
anoth
advantag
use
aciddegrad
vaccin
carrier
result
enhanc
immun
activ
dc
bridg
innat
nonspecif
immun
system
highli
specif
adapt
immun
sever
mechan
one
mediat
toll
like
receptor
tlr
recogn
uniqu
mo
b
fig
combin
differenti
interfacecontrast
dic
laserscan
confoc
micrograph
bmdc
incub
cation
nondegrad
aciddegrad
nanoparticl
b
h
intracellular
particl
locat
confirm
vari
focu
plane
lecular
pattern
pathogen
activ
cellular
pathway
requir
function
immun
respons
immunostimulatori
unmethyl
cpg
odn
coat
aciddegrad
cation
nanoparticl
incub
bmdc
h
activ
dc
quantifi
secret
polar
helper
cell
type
h
differenti
rather
h
eventu
assist
ctl
activ
fig
clearli
illustr
bmdc
produc
least
time
incub
cpg
odncoat
aciddegrad
nanoparticl
control
cell
alon
bmdc
incub
free
cpg
odn
nanoparticl
without
cpg
odn
similarli
odn
adsorb
onto
cation
aciddegrad
nanoparticl
secret
antagonist
cytokin
bmdc
inhibit
deliveri
odn
decreas
secret
observ
oligonucleotid
combin
cation
nanoparticl
fig
therefor
formul
aciddegrad
cation
nanoparticl
tune
produc
maximum
ctlmediat
immun
respons
stimul
secret
inhibit
express
dc
numer
interest
studi
carri
sinc
vaccin
reconsid
prevent
therapeut
tool
cancer
one
major
caus
death
western
societi
howev
discov
simpli
inject
cancer
antigen
suffici
activ
anticanc
immun
respons
cancer
cell
also
normal
cell
express
antigen
ie
cancerassoci
antigen
frequent
cancer
cell
downregul
mhc
molecul
express
cancer
antigen
insuffici
establish
cancer
cell
also
secret
cytokin
form
new
rigid
tumor
tissu
defens
immun
attack
therefor
develop
effici
cancer
vaccin
urgent
need
knowledg
understand
cancer
becom
avail
uniqu
cancer
antigen
identifi
design
effect
antigen
deliveri
vehicl
becom
critic
ideal
carrier
possess
properti
specif
target
effici
antigen
deliveri
activ
proper
immun
respons
facil
inexpens
prepar
simpl
administr
storag
studi
aciddegrad
cation
nanoparticl
use
deliv
model
antigen
ovalbumin
bmdc
evid
accumul
indic
dc
play
pivot
role
orchestr
immun
respons
activ
toler
dc
resid
antigenencount
area
skin
mucos
layer
antigen
uptak
matur
dc
migrat
lymphoid
organ
spleen
lymph
node
activ
b
cell
effici
present
antigenderiv
peptid
costimula
tori
molecul
result
secret
cytokin
high
concentr
upon
activ
dc
also
suscept
cell
viral
infect
like
human
inmmunodefici
viru
type
sever
acut
respiratori
syndrom
sar
coronaviru
viral
antigen
present
effici
also
shown
dc
link
innat
immun
adapt
immun
therefor
gener
consensu
target
prime
dc
critic
target
develop
success
vaccin
strategi
demonstr
aciddegrad
nanoparticl
significantli
effect
antigen
present
mhc
nondegrad
nanoparticl
fig
possibl
explan
find
protein
releas
cytoplasm
space
aciddegrad
particl
case
nondegrad
one
previous
hypothes
releas
small
molecul
aldehyd
hydrolysi
might
destabil
lysosom
membran
due
increas
osmot
pressur
follow
cytosol
releas
antigen
addit
swell
effect
hydrogel
nanoparticl
result
crosslink
cleavag
may
also
contribut
facil
releas
swell
could
lead
leaki
lysosom
membran
structur
howev
studi
must
undertaken
clarifi
cellular
behavior
aciddegrad
particl
sinc
still
dearth
support
evid
endosom
lysosom
escap
extracellular
molecul
exampl
believ
polycation
polym
eg
pei
aid
endosom
escap
proton
spong
effect
howev
theori
recent
critic
studi
variou
proton
group
indic
differ
endosom
escap
shown
fig
degrad
particl
favor
distribut
antigen
payload
throughout
cytoplasm
space
therebi
contribut
effici
present
antigenderiv
peptid
dc
matur
anoth
possibl
explan
enhanc
antigen
present
protect
protein
lysosom
degrad
encapsul
microenviron
nanoparticl
slow
even
negat
effect
proteas
minim
exposur
degrad
condit
lysosom
result
fast
releas
cytoplasm
therefor
protein
would
success
process
cytoplasm
present
mhc
molecul
cation
molecul
well
known
easili
intern
cell
includ
phagocyt
macrophag
dc
due
attract
interact
neg
charg
proteoglycan
cell
surfac
also
shown
rel
larg
cation
particl
even
larg
micron
diamet
could
taken
dc
effici
cation
nanoparticl
design
effici
endocytos
help
increas
deliveri
effici
sinc
antigen
protein
deliv
antigenderiv
peptid
present
therefor
increas
probabl
encount
cell
drawback
cation
molecul
cytotox
therefor
amount
administ
must
kept
minimum
may
result
low
effici
howev
demonstr
studi
cation
nanoparticl
could
deliv
ovalbumin
effici
neutral
one
toxic
two
type
nanoparticl
remain
compar
low
concentr
ie
ag
al
addit
advantag
use
cation
carrier
increas
endocytosi
cation
surfac
particl
adsorb
anion
molecul
dna
neg
bias
protein
previou
studi
polylactidecoglycol
acid
plga
particl
coat
cation
surfact
effect
adsorb
plasmid
dna
oligonucleotid
also
shown
gmcsf
isoelectr
point
adsorb
deliv
cation
particl
nanoparticl
use
studi
also
demonstr
abil
adsorb
neg
charg
dna
cation
surfac
ratio
easier
modul
nanoparticl
case
previous
report
system
due
progress
immunolog
reveal
immun
respons
result
cellcel
interact
complic
network
strict
control
respons
mediat
surfac
molecul
eg
receptor
andor
secret
macromolecul
eg
cytokin
unmethyl
cpg
dna
bind
locat
cell
surfac
migrat
endosom
lysosom
compart
apc
activ
secret
cytokin
eg
upregul
costimulatori
surfac
molecul
eg
recent
studi
report
tlr
also
regul
matur
phagosom
therefor
deliv
cpg
dna
help
ctl
activ
upregul
costimulatori
molecul
dc
surfac
encourag
secret
h
direct
immunostimulatori
respons
maxim
suppress
antagonist
secret
exampl
accomplish
deliv
antisens
oligonucleotid
shown
studi
fig
interestingli
studi
indic
crosspresentationpresent
extracellular
antigen
mhc
iof
cpg
dnaconjug
protein
induc
dc
mean
cpg
dna
help
stimul
innat
immun
also
amplifi
ctlmediat
immun
cellular
immun
rather
humor
immun
cytokin
releas
crosspresent
therefor
expect
cation
natur
aciddegrad
nanoparticl
use
studi
use
cancer
vaccin
carrier
capabl
adjust
immun
respons
cation
aciddegrad
nanoparticl
use
carrier
model
antigenovalbuminfor
proteinbas
vaccin
develop
enhanc
mhc
imedi
antigen
present
observ
appear
relat
aciddegrad
particl
cation
particl
endocytos
effici
neutral
one
although
amount
cation
densiti
particl
requir
optim
due
innat
cytotox
cation
speci
final
maxim
cellular
immun
achiev
deliv
antigen
adjuv
nucleotid
adsorb
onto
cation
surfac
aciddegrad
particl
